Ousted FDA official joins Lilly; Novo names global research head as layoffs come into focusnews2025-09-12T11:00:45+00:00September 12th, 2025|Endpoints News|
AbbVie staves off Rinvoq generics until 2037news2025-09-11T19:11:19+00:00September 11th, 2025|Endpoints News|
Alternative health plan startup XO Health raises $52.2Mnews2025-09-11T17:50:57+00:00September 11th, 2025|Endpoints News|
Prasad regains chief medical and scientific officer roles at FDAnews2025-09-11T17:25:23+00:00September 11th, 2025|Endpoints News|
RFK Jr.’s ‘historic changes’ to drug ads would trigger range of ripple effectsnews2025-09-11T15:41:30+00:00September 11th, 2025|Endpoints News|
Avidity shares fall after $500M offering, dimming hopes of a Novartis buyoutnews2025-09-11T15:19:21+00:00September 11th, 2025|Endpoints News|
LGC opens $72M chemical plant; Recipharm partners with NeuroSense news2025-09-11T15:12:39+00:00September 11th, 2025|Endpoints News|
Intercept pulls liver disease drug from market as FDA puts clinical trials on holdnews2025-09-11T14:48:53+00:00September 11th, 2025|Endpoints News|
Maze’s SLC6A19 inhibitor moves to Phase 2; GenFleet to go public in Hong Kongnews2025-09-11T14:43:29+00:00September 11th, 2025|Endpoints News|
